Category : treatments
First there was Botox, then there was Dysport, and now there is Xeomin (incobotulinumtoxinA). The Food and Drug Administration (FDA) recently approved this new botulinum toxin type A product to treat severe frown lines or “11’s” between the eyebrows. Xeomin was already FDA approved for use in adults with cervical dystonia and blepharospasm. Cervical dystonia is characterized by abnormal neck pain and movements, and blepharospasm is marked by abnormal, involuntary blinking or spasm of the eyelids. Xeomin is manufactured by Merz Pharmaceuticals, and has been used by more than 84,000 people worldwide. It is now approved for use in 20 countries.